User:Cmhu/sandbox

Dr. Wang founded United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York in 1985, and its group of companies in Asia : UBI Asia in 1998 , United Biopharma in 2013 , and UBI Pharma in 2014 respectively. Dr. Wang advocated “immunology as a secret weapon in medicine,” devoted decades of years in synthetic peptides technology. In 2009, Bill and Melinda Gates Foundation Awarded Grand Challenges Exploration Grants to Dr. Wang, for the Synthetic Peptides to Inhibit HIV Entry program.

The first involved developing a synthetic peptide-based HIV 1, and later an HIV 1,2 diagnostic test for blood screening, both of which received U.S. Food and Drug Administration approval, in 1989 and 1996, respectively. These tests were subsequently recognized by the World Health Organization (WHO) as being suitable for worldwide use.

Her other contributions in this area include synthetic peptide-based blood screening diagnostics for HTLV I/II and the Hepatitis C virus (HCV) (publication 53), which received CE mark certification and was sold in the global market through Organon Teknika /Biomerieux since 1991.